Harding; Joseph W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Harding; Joseph W..The latest application filed is for "hepatocyte growth factor mimics as therapeutic agents".

Company Profile

0.10.14

Harding; Joseph W. - Pullman WA
Harding; Joseph W - Pullman WA
Harding, Joseph W. - Pulman WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hepatocyte Growth Factor Mimics as Therapeutic Agents App 20170049843 - Harding; Joseph W. ; et al.	2017-02-23
Hepatocyte growth factor mimics as therapeutic agents Grant 9,150,613 - Harding , et al. October 6, 2	2015-10-06
C-Met receptor regulation by angiotensin IV (AT4) receptor ligands Grant 9,066,901 - Harding , et al. June 30, 2	2015-06-30
Hepatocyte growth factor mimics as therapeutic agents Grant 9,051,351 - Harding , et al. June 9, 2	2015-06-09
Hepatocyte Growth Factor (hgf) Mimics As Therapeutic Agents App 20140094413 - HARDING; JOSEPH W. ; et al.	2014-04-03
Hepatocyte Growth Factor Mimics as Therapeutic Agents App 20140088004 - Harding; Joseph W. ; et al.	2014-03-27
Hepatocyte Growth Factor Mimics as Therapeutic Agents App 20140051633 - Harding; Joseph W. ; et al.	2014-02-20
Hepatocyte growth factor mimics as therapeutic agents Grant 8,598,118 - Harding , et al. December 3, 2	2013-12-03
Hepatocyte Growth Factor Mimics As Therapeutic Agents App 20130165392 - Harding; Joseph W. ; et al.	2013-06-27
C-met Receptor Regulation By Angiotensin Iv (at4) Receptor Ligands App 20130023475 - Harding; Joseph W. ; et al.	2013-01-24
C-Met receptor regulation by angiotensin IV (AT.sub.4) receptor ligands Grant 8,236,761 - Harding , et al. August 7, 2	2012-08-07
C-Met receptor regulation by angiotensin IV (AT.sub.4 ) receptor ligands Grant 7,910,555 - Harding , et al. March 22, 2	2011-03-22
C-met Receptor Regulation By Angiotensin Iv (at4) Receptor Ligands App 20080293634 - Harding; Joseph W. ; et al.	2008-11-27
At4 Receptor Ligands As Angiogenic, Anti-angiogenic, And Anti-tumor Agents App 20080194490 - Harding; Joseph W. ; et al.	2008-08-14
C-met Receptor Regulation By Angiotensin Iv (at4) Receptor Ligands App 20080008701 - Harding; Joseph W. ; et al.	2008-01-10
AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents Grant 7,118,747 - Harding , et al. October 10, 2	2006-10-10
AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents App 20060128630 - Harding; Joseph W. ; et al.	2006-06-15
At4 Receptor Ligands As Angiogenic, Anti-angiogenic, And Anti-tumor Agents App 20050222044 - Harding, Joseph W. ; et al.	2005-10-06
Methods of identifying agonists or antagonists of angiotensin IV Grant 6,022,696 - Harding , et al. February 8, 2	2000-02-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.